These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 1612072)

  • 21. Statins and diabetes.
    Carmena R; Betteridge DJ
    Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipid-lowering effect of simvastatin in patients of type 2 diabetes mellitus.
    Udawat H; Goyal RK
    Indian Heart J; 2001; 53(2):172-6. PubMed ID: 11428472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statin therapy for the treatment of diabetic dyslipidemia.
    Haffner SM
    Diabetes Metab Res Rev; 2003; 19(4):280-7. PubMed ID: 12879405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Dyslipidemia in diabetes mellitus].
    Niemeijer-Kanters SD; Banga JD; Erkelens DW
    Ned Tijdschr Geneeskd; 2001 Apr; 145(16):769-74. PubMed ID: 11346913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pathogenesis and significance of diabetic dyslipidemia].
    Zeman M; Zák A
    Cas Lek Cesk; 2004; 143(5):302-6. PubMed ID: 15305764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of hyperlipidemia in diabetes mellitus].
    Onuma T; Kawamori R
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():143-51. PubMed ID: 11347047
    [No Abstract]   [Full Text] [Related]  

  • 27. [Lipid disorders in non-insulin dependent diabetes--principles of treatment].
    Idzior-Waluś B
    Przegl Lek; 1996; 53(9):653-9. PubMed ID: 8992531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetic dyslipidemia and atherosclerosis.
    Shepherd J
    Schweiz Med Wochenschr; 1994 Nov; 124(44):1933-7. PubMed ID: 7973520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipids in type 2 diabetes.
    Laakso M
    Semin Vasc Med; 2002 Feb; 2(1):59-66. PubMed ID: 16222596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of soybean D-LeciVita product on serum lipids and fatty acid composition in type 2 diabetic patients with hyperlipidemia.
    Ristić Medić D; Ristić V; Arsić A; Postić M; Ristić G; Blazencić Mladenović V; Tepsić J
    Nutr Metab Cardiovasc Dis; 2006 Sep; 16(6):395-404. PubMed ID: 16935698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The lipid triad in type 2 diabetes - prevalence and relevance of hypertriglyceridaemia/low high-density lipoprotein syndrome in type 2 diabetes.
    Temelkova-Kurktschiev T; Hanefeld M
    Exp Clin Endocrinol Diabetes; 2004 Feb; 112(2):75-9. PubMed ID: 15031770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term (18-month) efficacy of atorvastatin therapy in type 2 diabetics at cardiovascular risk.
    Velussi M
    Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):29-35. PubMed ID: 12125227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipid and lipoprotein profiles in Ethiopian patients with diabetes mellitus.
    Siraj ES; Seyoum B; Saenz C; Abdulkadir J
    Metabolism; 2006 Jun; 55(6):706-10. PubMed ID: 16713427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dyslipidemia and diabetes: animal models.
    Mathé D
    Diabete Metab; 1995 Apr; 21(2):106-11. PubMed ID: 7621969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dyslipidaemia in diabetes mellitus. Review of the main lipoprotein abnormalities and their consequences on the development of atherogenesis.
    Vergès BL
    Diabetes Metab; 1999 Jun; 25 Suppl 3():32-40. PubMed ID: 10421991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipoprotein disorders in diabetes mellitus.
    O'Neill WC
    J Med Assoc Ga; 1989 Nov; 78(11):771-3. PubMed ID: 2691606
    [No Abstract]   [Full Text] [Related]  

  • 37. Pathogenesis of dyslipidemia in type 2 diabetes.
    Taskinen MR
    Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S180-8. PubMed ID: 11460569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of policosanol and lovastatin on lipid profile and lipid peroxidation in patients with dyslipidemia associated with type 2 diabetes mellitus.
    Castaño G; Menéndez R; Más R; Amor A; Fernández JL; González RL; Lezcay M; Alvarez E
    Int J Clin Pharmacol Res; 2002; 22(3-4):89-99. PubMed ID: 12837046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperlipidemia and cardiovascular risk factors in patients with type 2 diabetes.
    Goldberg RB
    Am J Manag Care; 2000 Aug; 6(13 Suppl):S682-91; discussion S692-6. PubMed ID: 11183421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Lipid control in diabetic patients in Extremadura (Spain)].
    Roberto Robles N; Barroso S; Marcos G; Sánchez Muñoz-Torrero JF;
    Endocrinol Nutr; 2009 Mar; 56(3):112-7. PubMed ID: 19627723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.